ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Investment

Bill Gates backs Alzheimer’s diagnostics with new Diagnostics Accelerator venture fund

by Ryan Cross
July 20, 2018 | APPEARED IN VOLUME 96, ISSUE 30

 

Bill Gates is pumping more money into Alzheimer’s research. Gates and other philanthropists, including Alzheimer’s Drug Discovery Foundation cofounder Leonard Lauder, will invest more than $30 million in a new venture fund called Diagnostics Accelerator. The fund will back researchers developing better ways to diagnose the neurodegenerative disease, since drugs are more likely to treat it if it is diagnosed early. In November, Gates pledged $50 million to the Dementia Discovery Fund in the U.K.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment